• PURE Biosciences completed a private placement on April 30, 2026, raising USD 1 million from accredited investors.
• Issued 18,131,096 common shares at USD 0.06 per share in an unregistered sale.
• Board members Tom Y. Lee invested about USD 700,000 through himself and affiliates; Ivan Chen invested USD 27,650.
• Net proceeds expected to support general corporate purposes, including R&D, administrative expenses, working capital.
• Shares sold under Section 4(a)(2) exemption, Rule 506 of Regulation D.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PURE Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-021329), on May 05, 2026, and is solely responsible for the information contained therein.